RecruitingPhase 3NCT05879926Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Sponsor: NRG OncologyAlma, MI · Alpena, MI · Ann Arbor, MI · +1223 more sites
RecruitingNot applicableNCT07227831A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast CancerSponsor: Barbara Ann Karmanos Cancer InstituteBay City, MI · Clarkston, MI · Detroit, MI · +5 more sites
RecruitingPhase 3NCT04852887De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Sponsor: NRG OncologyAnn Arbor, MI · Battle Creek, MI · +809 more sites
RecruitingNot applicableNCT07218432A Study of the TheraBionic P1 Device in Breast CancerSponsor: Barbara Ann Karmanos Cancer InstituteClarkston, MI · Detroit, MI · Farmington Hills, MI · +5 more sites
RecruitingPhase 3NCT05929768Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerSponsor: SWOG Cancer Research NetworkAdrian, MI · Alma, MI · Alpena, MI · +952 more sites